TrialFrontiers in endocrinology2022

Comparative Evaluation of Chiglitazar and Sitagliptin on the Levels of Retinol-Binding Protein 4 and Its Correlation With Insulin Resistance in Patients With Type 2 Diabetes.

Yunting Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.